Disease | breast cancer |
Symptom | C0042963|vomiting |
Sentences | 11 |
PubMedID- 25248897 | In this report, we highly recommend the coadministration of first-generation serotonin receptor antagonists, dexamethasone, and aprepitant for chemotherapy-associated nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide (ac) chemotherapy. |
PubMedID- 25508629 | The objective of this study was to analyze the incidence of chemotherapy-induced nausea and vomiting in women with breast cancer and identify strategies used by them to control these signs and symptoms. |
PubMedID- 22201663 | Purpose/objectives: to evaluate the effects of pericardium 6 (p6) acupressure and nurse-provided counseling on chemotherapy-induced nausea and vomiting (cinv) in patients with breast cancer. |
PubMedID- 24787745 | Objective: the purpose of this study was to determine the effect of acupressure applied to the pericardium 6 (p6 or neiguan) acupuncture point on chemotherapy-induced nausea, vomiting, and anxiety in patients with breast cancer. |
PubMedID- 25474850 | The objective of this study was to analyze the incidence of chemotherapy-induced nausea and vomiting in women with breast cancer and identify strategies used by them to control these signs and symptoms. |
PubMedID- 26414587 | Oral intake of ginger for chemotherapy-induced nausea and vomiting among women with breast cancer. |
PubMedID- 20565829 | The associations of breast cis or invasive breast cancer with nausea or vomiting during pregnancy or preeclampsia were explored among postmenopausal women with at least one pregnancy as reported at cohort entry who had complete information on one or both of these variables in the second mailed questionnaire. |
PubMedID- 25119858 | Our pooled analysis has demonstrated that regimens containing lapatinib are associated with a significantly increased risk of high-grade diarrhea, vomiting and stomatitis in patients with breast cancer. |
PubMedID- 25404883 | Neuropharmacology and management of chemotherapy-induced nausea and vomiting in patients with breast cancer. |
PubMedID- 24552088 | Assessment of chemotherapy-induced nausea and vomiting in women with breast cancer: a neuman systems model framework. |
PubMedID- 23950658 | Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the uk. |
Page: 1